Daniel Kwon MD

GU and hospital-based oncology @UCSFCancer 👉patient decision-making support and survivorship

[Sam Brondfield, MD, MAEd, FASCO @s_brond]

🎉 Great work @Kevin_Reyes650, @danielkwonmd and team describing the decision-related needs of people newly diagnosed with #cancer while hospitalized. Multiple perspectives included: patients, caregivers, oncologists.

Check it out: https://t.co/t0Xu3ICfx1

@UCSFCancer @UCSFDHM

[Sam Brondfield, MD, MAEd, FASCO @s_brond]

So excited for @UCSFMedicine 1st year medical student Joy Huang who is an amazing researcher! I’m lucky to have connected with her. 🙌🍀 #ASCO23

[UroToday.com @urotoday]

Skeletal-related events after abiraterone or enzalutamide in patients with #mCRPC: a population-based study using the SEER-Medicare Linked Dataset. #BeyondTheAbstract with @danielkwonmd @UCSFCancer on UroToday > https://t.co/wbB0avYNGT @UrolOncol @mbucknor @HalaBorno

[Daniel Kwon MD @danielkwonmd]

A collaborative effort between UCSFs Cancer Genetics and Prevention Program and GU Medical Oncology. @UCSFCancer

[JCO Oncology Practice @JCOOP_ASCO]

A hybrid oncologist/genetic counselor–delivered model is a feasible for high-volume #germlinetesting in men w #prostateCancer #pcSM (both in person & via #telehealth 💻); it does not eliminate racial disparities in testing access however. 👉 https://t.co/87Y2mADRmE @danielkwonmd

[UroToday.com @urotoday]

Skeletal-related events after abiraterone or enzalutamide in patients with #mCRPC: a population-based study using the SEER-Medicare Linked Dataset. #BeyondTheAbstract with @danielkwonmd @UCSFCancer on UroToday > https://t.co/wbB0avYNGT @UrolOncol @mbucknor @HalaBorno

[UroToday.com @urotoday]

Skeletal-related events after abiraterone or enzalutamide in patients with #mCRPC: a population-based study using the SEER-Medicare Linked Dataset. #BeyondTheAbstract with @danielkwonmd @UCSFCancer on UroToday > https://t.co/wbB0awgoyr @UrolOncol @mbucknor @HalaBorno

[Daniel Kwon MD @danielkwonmd]

Thanks @cancerGRACE for producing this 7-part series I did with Fred on high quality decision making in advanced prostate ca. We talk about why this is important, steps, and resources. Applicable to all cancers! https://t.co/MmovDIsBYH

[GRACE @cancerGRACE]

In this video from our past year's Patient Education Ambassador Program, Dr. @danielkwonmd & Fred discuss his first option: starting hormone treatment immediately and its risks/benefits.

https://t.co/CgyW40XK6u
#prostatecancer #cancer #exelixis #lilly #genentech #hormonetherapy

[Daniel Kwon MD @danielkwonmd]

In this @JAMAOnc Patient Page, we (@AnaVManana @ivandk3) wrote an easy-to-understand explanation of PSMA PET Scans in prostate cancer. https://t.co/5NJcRob28n Great resource for patients. @cancerGRACE

[Daniel Kwon MD @danielkwonmd]

@s_brond @UCSFCancer ☺️ I learn from only the best.

[Thomas Hope @thomashopemd]

It's rough to wait so long to get 177Lu-PSMA-617 therapy available, and then see a patient who is in such need with a scan that would suggest great benefit (SUVs in the 60s), and then find out that doses can't be delivered for an unknown amount of time. Unbelievable!

[Daniel Kwon MD @danielkwonmd]

@MazieTsangMD @AnaVManana @cancerGRACE @FernandoDiazMD1 @JackWestMD @AmyBickleman Congrats! Excited to see all the content you create!

[Daniel Kwon MD @danielkwonmd]

@MazieTsangMD @AnaVManana Hana asks for Encanto (and Coco) everyday!

[Thomas Hope @thomashopemd]

Finally! FDA approves 177Lu-PSMA-617. Somewhat odd name (Pluvicto). Can't wait to see the prescribing information.

[Daniel Kwon MD @danielkwonmd]

@egnij @UCSFCancer @FranklinHuang Thanks Jin!

[UCSF Helen Diller Family Comprehensive Cancer Ctr @UCSFCancer]

COVID‐19 outcomes in patients with cancer: Findings from the University of California health system database | @danielkwonmd @FranklinHuang in the journal Cancer Medicine https://t.co/ENfU0EyNJk #openaccess

[Sam Brondfield, MD, MAEd, FASCO @s_brond]

Hey #oncologists and @HemOncFellows! We’re recruiting a new @UCSFHospitals hospital-based oncologist (#HBO)! Come join our growing inpatient solid onc group w @danielkwonmd and me @UCSFCancer 🥰
Apply: https://t.co/RViPpqWiBu
Why I ❤️ #HBO: https://t.co/Uh6DgHyTG8
🩺🥼🏥🥰

[Daniel Kwon MD @danielkwonmd]

@tpjmd This is beautiful

[Tyler Johnson @tpjmd]

https://t.co/p7FJwIP1wZ thanks to the Mercury News for publishing my reflection on what doctoring has taught me about processing the irreplaceable losses of the pandemic.

[Sam Brondfield, MD, MAEd, FASCO @s_brond]

Hiring AHP (NP/PA) for @UCSFCancer hospital-based oncology #HBO service! Internal and external AHPs welcome: https://t.co/ocppm7KvNF https://t.co/P8139jjOdP https://t.co/Qu5Sed4nWz https://t.co/D1TTCqifA9
Work w sweet (@danielkwonmd) and sassy (🙋🏻‍♂️) attendings 😝 @UCSFHospitals

[Daniel Kwon MD @danielkwonmd]

@RahulBanerjeeMD @UWMedicine @fredhutch @MaryKwok1 @uwmnewsroom @SeattleCCA @StephanieLeeMD @FHsurvivorship @JoshuaLiaoMD Congrats!!! We will miss you!!